AOP-Wiki

API

All KERs

Showing 676 to 700 of 3081 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

1665	1473: Decrease, Chlorophyll synthesis	1474: Decrease, Light harvest capacity	Oct 10, 2017	Oct 10, 2017	1 AOP 245: Reduction in photophosphorylation leading to growth inhibition in aquatic plants
1347	1266: Decrease, Circulating CCAP	1267: Decrease, Ecdysis motor program activity	Feb 9, 2017	Feb 9, 2017	3 AOPs 4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1 342: Ecdysone receptor hyperactivation leading to mortality via mis-timed activation of nuclear receptor cascade 343: Ecdysone receptor antagonism leading to mortality via mis-timed ecdysone receptor-responsive nuclear receptor cascade
1000	988: Decrease, Circulating ETH	990: Increase, Incomplete ecdysis	Nov 29, 2016	Dec 3, 2016	None
1008	988: Decrease, Circulating ETH	993: Decrease, Abdominal muscle contraction	Nov 29, 2016	Dec 3, 2016	None
1346	988: Decrease, Circulating ETH	1266: Decrease, Circulating CCAP	Feb 9, 2017	Feb 9, 2017	3 AOPs 4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1 342: Ecdysone receptor hyperactivation leading to mortality via mis-timed activation of nuclear receptor cascade 343: Ecdysone receptor antagonism leading to mortality via mis-timed ecdysone receptor-responsive nuclear receptor cascade
2126	1690: Decrease, circulating testosterone levels	1613: Decrease, DHT level	May 11, 2020	Oct 19, 2023	1 AOP 288: Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)
2131	1690: Decrease, circulating testosterone levels	1614: Decrease, AR activation	May 11, 2020	Feb 4, 2026	4 AOPs 288: Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals) 307: Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring 570: Decreased testosterone synthesis leading to hypospadias in male (mammalian) offspring 575: Decreased testosterone synthesis leading to increased nipple retention (NR) in male (rodent) offspring
3169	1690: Decrease, circulating testosterone levels	2212: Epididymal agenesis	Mar 20, 2024	Dec 3, 2024	1 AOP 526: Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis
3202	1690: Decrease, circulating testosterone levels	809: malformed, Male reproductive tract	Apr 25, 2024	Apr 25, 2024	1 AOP 124: HMG-CoA reductase inhibition leading to decreased fertility
3205	1690: Decrease, circulating testosterone levels	348: Malformation, Male reproductive tract	May 1, 2024	May 1, 2024	1 AOP 18: PPARα activation in utero leading to impaired fertility in males
3206	1690: Decrease, circulating testosterone levels	414: Increase, Luteinizing hormone (LH)	May 1, 2024	May 1, 2024	1 AOP 51: PPARα activation leading to impaired fertility in adult male rodents
3213	1690: Decrease, circulating testosterone levels	219: Reduction, Plasma 17beta-estradiol concentrations	May 8, 2024	May 8, 2024	1 AOP 496: Androgen receptor agonism leading to reproduction dysfunction （in zebrafish）
3214	1690: Decrease, circulating testosterone levels	2139: Reduction, the ratio of E2/11-KT in plasma	May 8, 2024	May 8, 2024	1 AOP 496: Androgen receptor agonism leading to reproduction dysfunction （in zebrafish）
3225	1690: Decrease, circulating testosterone levels	520: Decreased sperm quantity or quality in the adult, Decreased fertility	May 24, 2024	May 24, 2024	1 AOP 64: Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility
3227	1690: Decrease, circulating testosterone levels	791: Increased, Leutinizing hormone (LH)	May 24, 2024	May 24, 2024	1 AOP 120: Inhibition of 5α-reductase leading to Leydig cell tumors (in rat)
3349	1690: Decrease, circulating testosterone levels	1688: AGD, decreased	Oct 1, 2024	May 6, 2025	1 AOP 307: Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring
3350	1690: Decrease, circulating testosterone levels	2082: Hypospadias	Oct 1, 2024	Sep 18, 2025	1 AOP 570: Decreased testosterone synthesis leading to hypospadias in male (mammalian) offspring
3486	1690: Decrease, circulating testosterone levels	1786: nipple retention, increased	Jan 30, 2025	Sep 17, 2025	1 AOP 575: Decreased testosterone synthesis leading to increased nipple retention (NR) in male (rodent) offspring
3620	1690: Decrease, circulating testosterone levels	1758: Impaired, Spermatogenesis	Sep 3, 2025	Sep 3, 2025	1 AOP 595: Emerging OPFRS reproductive outcome pathway
1600	1446: Decrease, Coupling of OXPHOS	40: Mitochondrial ATP production, decreased	Jun 29, 2017	Jun 29, 2017	None
2175	1446: Decrease, Coupling of OXPHOS	1808: Decrease, ATP synthase activity	Nov 2, 2020	Nov 2, 2020	None
2182	1446: Decrease, Coupling of OXPHOS	1811: Increase, Complex III dysfunction	Nov 2, 2020	Nov 2, 2020	None
2188	1446: Decrease, Coupling of OXPHOS	1813: Increase, Complex I dysfunction	Nov 2, 2020	Nov 2, 2020	None
2203	1446: Decrease, Coupling of OXPHOS	1771: Decrease, ATP pool	Nov 12, 2020	Jul 6, 2022	11 AOPs 263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation 264: Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death 266: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity 324: Excessive reactive oxygen species leading to growth inhibition via uncoupling of oxidative phosphorylation and cell death 325: Excessive reactive oxygen species leading to growth inhibition via uncoupling of oxidative phosphorylation and reduced cell growth 326: Excessive reactive oxygen species leading to growth inhibition via uncoupling of oxidative phosphorylation and reduced cell proliferation 331: Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death 332: Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and reduced cell growth 333: Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and reduced cell proliferation 596: Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell injury/death 612: Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via reduced adenosine triphosphate
2219	1446: Decrease, Coupling of OXPHOS	1826: Increase, Oxygen consumption	Dec 4, 2020	Dec 4, 2020	None

Key Event Relationships (KERs)

All KERs